Skip to main content
Premium Trial:

Request an Annual Quote

SEngine Precision Medicine Licenses Hutch Cancer Drug Screening Assay

NEW YORK (GenomeWeb) – SEngine Precision Medicine has inked an exclusive licensing agreement with the Fred Hutchinson Cancer Research Center to market a diagnostic test designed to aid in the personalization of cancer treatments.

The assay, called PARIS, combines high-throughput drug screening of live, patient-derived tumor cells with DNA sequencing and data analysis to match individuals with optimal drug therapies.

The licensing deal also includes Hutch intellectual property and know-how related to more than 100 novel drug targets related to cancer growth. SEngine plans to investigate these targets for their response to small-molecule inhibitors in an effort to design more effective therapies.

"Forging this relationship with the Fred Hutchinson Cancer Research Center marks an important step toward our goal of harnessing the latest in technology and science in order to provide cancer patients with personalized, targeted, and less toxic treatment options," SEngine CEO Carla Grandori said in a statement. "The PARIS test has the potential to spare cancer patients unnecessary treatments, and improve quality and length of life as treatments are identified."

SEngine's lab recently received CLIA certification, allowing it to perform customized, high-throughput drug chemosensitivity screening for all solid tumor types on live, patient-derived cells.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.